Biosect,
I believe practically every trial sponsored by a company has someone from the company named in the clinical trials database as coordinating the trial from the company. In our case this person is Dr. Bosch. My point is that this person will be part of all that's released about trial results by anyone as a participant in most anything released about the trial, including Journal publications.
If I'm right about this, H-G's or anyone else's claim that that person brings a bias into publications, presentations, etc. is something that can be said for practically all such things. Such people may not be involved if the company has no sponsorship in the trial, like the ones being done at UCLA, but I believe that nearly all Phase 3 Trials have corporate sponsors.
Like so many of H-G's claims, what NWBO is doing is no different than what nearly every biotech or BP does when it comes to bringing a product to approval. Certainly some companies, especially those with unlimited funds, may do it faster, but nonetheless it gets done.
Gary
Market Data 
Markets 
AI
